Investor Jorey Chernett has filed an amended Schedule 13G/A, revealing beneficial ownership of 2,339,009 American Depositary Shares in Kazia Therapeutics. This filing updates previous disclosures regarding his stake in the NASDAQ-listed company.
Jorey Chernett Discloses Multi-Million ADS Stake in Kazia Therapeutics
Insider FilingsShareholder DisclosureNASDAQInvestment



